These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 33081816)
1. Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study. Ng DL; Malik NMBA; Chai CS; Goh GM; Tan SB; Bee PC; Gan GG; Said AB Health Qual Life Outcomes; 2020 Oct; 18(1):347. PubMed ID: 33081816 [TBL] [Abstract][Full Text] [Related]
2. Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study. Selby R; Kaus L; Sealey F; Koo M; Parpia S; Chan B; Seung SJ; Bradley C; Strauss R; Mittmann N PLoS One; 2023; 18(4):e0284425. PubMed ID: 37071625 [TBL] [Abstract][Full Text] [Related]
3. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study. Li Y; Yu J; Kuang Y; Wu C; Yang L; Fang Q; Pei Q; Yang G Curr Med Res Opin; 2020 Sep; 36(9):1433-1439. PubMed ID: 32677855 [TBL] [Abstract][Full Text] [Related]
4. SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation. Krittayaphong R; Winijkul A; Pirapatdit A; Chiewvit P; Komoltri C; Boonyapisit W; Arunsiriwattana S; Bunyapipat T; Apiyasawat S; Rattanasumawong K; Yindeengam A; Singapore Med J; 2020 Dec; 61(12):641-646. PubMed ID: 31680175 [TBL] [Abstract][Full Text] [Related]
5. Chinese stroke patients with atrial fibrillation used Robert's age-adjusted warfarin loading protocol obtained good INR results within therapeutic range. Luo W; Luo X; Chen S; Li J; Huang X; Rao Y; Xu W Sci Rep; 2023 Oct; 13(1):18230. PubMed ID: 37880296 [TBL] [Abstract][Full Text] [Related]
6. Patients' time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic. Lee SL; Ong TJ; Mazlan-Kepli W; Mageswaran A; Tan KH; Abd-Malek AM; Cronshaw R World J Cardiol; 2021 Sep; 13(9):483-492. PubMed ID: 34621493 [TBL] [Abstract][Full Text] [Related]
7. Patient factors against stable control of warfarin therapy for Japanese non-valvular atrial fibrillation patients. Tomita H; Kadokami T; Momii H; Kawamura N; Yoshida M; Inou T; Fukuizumi Y; Usui M; Funakoshi K; Yamada S; Aomori T; Yamamoto K; Uno T; Ando S; Thromb Res; 2013 Nov; 132(5):537-42. PubMed ID: 24071466 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry. Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825 [TBL] [Abstract][Full Text] [Related]
9. Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation. Deitelzweig S; Evans M; Hillson E; Trocio J; Bruno A; Tan W; Lingohr-Smith M; Singh P; Lin J Curr Med Res Opin; 2016; 32(1):87-94. PubMed ID: 26451675 [TBL] [Abstract][Full Text] [Related]
10. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada. McAlister FA; Wiebe N; Hemmelgarn BR BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672 [TBL] [Abstract][Full Text] [Related]
11. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation. Vinding NE; Bonde AN; Rørth R; Lamberts M; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL Europace; 2019 Apr; 21(4):572-580. PubMed ID: 30508073 [TBL] [Abstract][Full Text] [Related]
12. Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin. Kosum P; Siranart N; Nissaipan K; Laohapiboolrattana W; Sowalertrat W; Triamamornwooth K; Arunphan R; Sriyom A; Rungpradubvong V Sci Rep; 2024 May; 14(1):11647. PubMed ID: 38773162 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation. Srinonprasert V; Ratanasumawong K; Thongsri T; Dutsadeevettakul S; Jittham P; Wiwatworapan W; Krittayaphong R; Qual Life Res; 2019 Aug; 28(8):2091-2098. PubMed ID: 30953293 [TBL] [Abstract][Full Text] [Related]
14. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention. Hirano T; Kaneko H; Mishina S; Wang F; Morita S J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients receiving oral anti-coagulants: a cross-sectional study. Sridharan K; Al Banny R; Qader AM; Husain A; Qader KM Expert Rev Cardiovasc Ther; 2020 May; 18(5):309-314. PubMed ID: 32324434 [TBL] [Abstract][Full Text] [Related]
16. Quality of warfarin control in atrial fibrillation patients in South East Queensland, Australia. Bernaitis N; Badrick T; Davey AK; Anoopkumar-Dukie S Intern Med J; 2016 Aug; 46(8):925-31. PubMed ID: 27040159 [TBL] [Abstract][Full Text] [Related]
17. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center. Baker JW; Pierce KL; Ryals CA J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546 [TBL] [Abstract][Full Text] [Related]
18. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED; Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina. Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M; Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia. Yimer NS; Abiye AA; Hussen SU; Tadesse TA Clin Appl Thromb Hemost; 2021; 27():10760296211049786. PubMed ID: 34724849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]